Drug History: ZIAGEN

DRUGS THAT CAUSES A FALSE POSITIVE ON A DRUG TEST

Browse by Letter: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9

Label and Approval History

Drug Name:	ZIAGEN
FDA Application No:	(NDA) 020977
Active Ingredient(s):	ABACAVIR SULFATE
Company:	GLAXOSMITHKLINE

Label History

View the label approved on May 9, 2007 for ZIAGEN, (NDA) 020977

To see older, previously-approved labels, go to the "Approval History" section of this page. Older labels are for historical information only and should not be used for clinical purposes.

Approval History

Action Date	Supplement Number	Approval Type	Letters, Reviews, Labels, Patient Package Insert
5/7/2007	016	Labeling Revision	Letter Label
8/11/2006	014	Labeling Revision	Letter Label Review
7/26/2004	013	Labeling Revision	Letter Label
8/2/2004	012	New Dosage Regimen	Letter Label Review
4/15/2004	011	Accelerated Approval	Letter Label
7/17/2003	010	Labeling Revision	Letter Label
8/14/2002	008	Labeling Revision	Letter Label
10/2/2002	007	Labeling Revision	Letter Label
6/4/2002	006	Labeling Revision
1/28/2002	005	Labeling Revision	Letter
7/13/2001	004	Control Supplement
7/27/2000	003	Labeling Revision
12/15/2000	002	Efficacy Supplement with Clinical Data to Support	Review Medication Guide
4/20/2000	001	Labeling Revision
12/17/1998	000	Approval	Letter Label Review Medication Guide Consumer Information Sheet

There are no Therapeutic Equivalents